ConductScience.org, home

Paper438117

Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.

Robinson JM and 2 others. J Bacteriol, 1979. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. Papers, record 438117. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/438117

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.
PubMed
Journal
J Bacteriol
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Robinson JMJ M
2Hardman JKJ K
3Sloan GLG L

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LysostaphinMajor topic
PeptidoglycanMajor topic
StaphylococcusMajor topic
Cell Wall
Drug Resistance, Microbial
Mutation

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114292833PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS.Biochim Biophys Acta1965https://conductscience.org/library/papers/14292833PubMed
214324964A BIOCHEMICAL CHARACTERIZATION OF HISTIDINE-DEPENDENT MUTANTS OF STAPHYLOCOCCUS AUREUS.J Gen Microbiol1965https://conductscience.org/library/papers/14324964PubMed
314317407LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.Biochem Biophys Res Commun1965https://conductscience.org/library/papers/14317407PubMed
414272478THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.Can J Microbiol1964https://conductscience.org/library/papers/14272478PubMed
514171453LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.Proc Natl Acad Sci U S A1964https://conductscience.org/library/papers/14171453PubMed
71015951Chemical and biochemical studies for the differentiation of coagulase-positive staphylococci.Arch Microbiol1976https://conductscience.org/library/papers/1015951PubMed
8588262Lysostaphin endopeptidase-catalysed transpeptidation reactions of the imino-transfer type.Biochem J1977https://conductscience.org/library/papers/588262PubMed
94960294Mechanisms of enzymatic bacteriaolysis. Cell walls of bacteri are solubilized by action of either specific carbohydrases or specific peptidases.Science1967https://conductscience.org/library/papers/4960294PubMed
104276349In vitro incorporation of serine into the staphylococcal cell wall.Infect Immun1974https://conductscience.org/library/papers/4276349PubMed
114200845Mode of action of glycine on the biosynthesis of peptidoglycan.J Bacteriol1973https://conductscience.org/library/papers/4200845PubMed
124568761Peptidoglycan types of bacterial cell walls and their taxonomic implications.Bacteriol Rev1972https://conductscience.org/library/papers/4568761PubMed
134764725Classification of staphylococci based on chemical and biochemical properties.Arch Mikrobiol1973https://conductscience.org/library/papers/4764725PubMed
144773876Studies on lysostaphin. Separation and characterization of three enzymes.Eur J Biochem1973https://conductscience.org/library/papers/4773876PubMed
154996631Studies on endo-beta-acetylglucosaminidase, staphylolytic peptidase, and N-acetylmuramyl-L-alanine amidase in lysostaphin and from Staphylococcus aureus.Acta Pathol Microbiol Scand B Microbiol Immunol1971https://conductscience.org/library/papers/4996631PubMed
165785235Structures of the cell wall peptidoglycans of Staphylococcus epidermidis Texas 26 and Staphylococcus aureus Copenhagen. I. Chain length and average sequence of cross-bridge peptides.Biochemistry1969https://conductscience.org/library/papers/5785235PubMed
175686014Optical configuration of staphylococcal cell wall serine.J Bacteriol1968https://conductscience.org/library/papers/5686014PubMed
185675508Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.Appl Microbiol1968https://conductscience.org/library/papers/5675508PubMed
195956066Staphylococcal strains with relation to lysostaphin sensistivity.Nature1966https://conductscience.org/library/papers/5956066PubMed
205922547Elevated cell wall serine in pleiotropic staphylococcal mutants.J Bacteriol1966https://conductscience.org/library/papers/5922547PubMed

Download CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
41519724Turbid but accurate: automating lysostaphin quantification including uncertainty quantification.Microb Cell Fact2026https://conductscience.org/library/papers/41519724PubMed
39274911Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens.Molecules2024https://conductscience.org/library/papers/39274911PubMed
33348544A Simple Protocol for the Determination of Lysostaphin Enzymatic Activity.Antibiotics (Basel)2020https://conductscience.org/library/papers/33348544PubMed
32759309FmhA and FmhC of Staphylococcus aureus incorporate serine residues into peptidoglycan cross-bridges.J Biol Chem2020https://conductscience.org/library/papers/32759309PubMed
32482719The length of lipoteichoic acid polymers controls Staphylococcus aureus cell size and envelope integrity.J Bacteriol2020https://conductscience.org/library/papers/32482719PubMed
28516285Intracellular morphological changes in Staphylococcus aureus induced by treatment with sodium hypochlorite.Med Mol Morphol2017https://conductscience.org/library/papers/28516285PubMed
28046082The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.PLoS One2017https://conductscience.org/library/papers/28046082PubMed
27713293Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Pharmaceuticals (Basel)2010https://conductscience.org/library/papers/27713293PubMed
23571534Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23571534PubMed
23076591Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus.Appl Microbiol Biotechnol2012https://conductscience.org/library/papers/23076591PubMed
20729317Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.Appl Environ Microbiol2010https://conductscience.org/library/papers/20729317PubMed
17101683Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17101683PubMed
16923896Staphylococcus aureus mutants with increased lysostaphin resistance.J Bacteriol2006https://conductscience.org/library/papers/16923896PubMed
15716447Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype.J Bacteriol2005https://conductscience.org/library/papers/15716447PubMed
12019130Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12019130PubMed
11525982Self-protection against cell wall hydrolysis in Streptococcus milleri NMSCC 061 and analysis of the millericin B operon.Appl Environ Microbiol2001https://conductscience.org/library/papers/11525982PubMed
10762270Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the Staphylococcal peptidoglycan interpeptide bridge.J Bacteriol2000https://conductscience.org/library/papers/10762270PubMed
9209049epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.J Bacteriol1997https://conductscience.org/library/papers/9209049PubMed
8953725Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881.Appl Environ Microbiol1996https://conductscience.org/library/papers/8953725PubMed
8892834A vancomycin-inducible lacZ reporter system in Bacillus subtilis: induction by antibiotics that inhibit cell wall synthesis and by lysozyme.J Bacteriol1996https://conductscience.org/library/papers/8892834PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/438117

GET https://conductscience.org/api/papers/v1/438117/cited_by?page=2